Recent studies have documented that HIV-positive patients with tuberculosis (TB) who receive antiretroviral therapy (ART) within two weeks of beginning anti-tuberculosis treatment have lower mortality, particularly at low CD4 counts [1]–[4]. This evidence concerns the gene CD4 and tuberculosis.